Fingolimod -Response According to Coping - Evaluation

Summary

This is a prospective, open-label, multi-center phase IV study to assess response to fingolimod initiation according to coping profile in adult patients with highly active relapsing remitting multiple sclerosis in France.

Timeline

Start

2011-08

Primary completion

2013-06

Completion

2013-06

Drugs

Indications